[1]
|
Albanese, A., Bhatia, K., Bressman, S.B., et al. (2013) Phenomenology and Classification of Dystonia: A Consensus Update. Movement Disorders, 28, 863-873. https://doi.org/10.1002/mds.25475
|
[2]
|
The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group (2000) A Prevalence Study of Primary Dystonia in Eight European Countries. Journal of Neurology, 247, 787-792. https://doi.org/10.1007/s004150070094
|
[3]
|
Defazio, G., Hallett, M., Jinnah, H.A., Conte, A. and Berardelli, A. (2017) Blepharospasm 40 Years Later. Movement Disorders, 32, 498-509. https://doi.org/10.1002/mds.26934
|
[4]
|
Simpson, D.M., Hallett, M., Ashman, E.J., et al. (2016) Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 86, 1818-1826.
https://doi.org/10.1212/WNL.0000000000002560
|
[5]
|
Bhidayasiri, R., Cardoso, F. and Truong, D.D. (2006) Bot-ulinum Toxin in Blepharospasm and Oromandibular Dystonia: Comparing Different Botulinum Toxin Preparations. Eu-ropean Journal of Neurology, 13, 21-29.
https://doi.org/10.1111/j.1468-1331.2006.01441.x
|
[6]
|
Dong, H., Luo, Y., Fan, S., et al. (2019) Screening Gene Mutations in Chinese Patients with Benign Essential Blepharospasm. Frontiers in Neurology, 10, Article 1387. https://doi.org/10.3389/fneur.2019.01387
|
[7]
|
Sun, Y., Tsai, P.-J., Chu, C.-L., Huang, W.-C. and Bee, Y.-S. (2018) Epidemiology of Benign Essential Blepharospasm: A Nationwide Population-Based Retrospective Study in Taiwan. PLOS ONE, 13, e0209558.
https://doi.org/10.1371/journal.pone.0209558
|
[8]
|
赵晶晶. 良性特发性眼睑痉挛的研究与治疗新进展[J]. 中国疗养医学, 2019, 28(11): 1147-1150.
|
[9]
|
Etgen, T., Mühlau, M., Gaser, C. and Sander, D. (2006) Bilateral Grey-Matter Increase in the Putamen in Primary Blepharospasm. Journal of Neurology, Neurosurgery & Psychiatry, 77, 1017-1020.
https://doi.org/10.1136/jnnp.2005.087148
|
[10]
|
Suzuki, Y., Mizoguchi, S., Kiyosawa, M., et al. (2007) Glucose Hypermetabolism in the Thalamus of Patients with Essential Blepharospasm. Journal of Neurology, 254, 890-896. https://doi.org/10.1007/s00415-006-0468-5
|
[11]
|
Pandey, S. and Sharma, S. (2017) Meige’s Syndrome: History, Epidemiology, Clinical Features, Pathogenesis and Treatment. Journal of the Neurological Sciences, 372, 162-170. https://doi.org/10.1016/j.jns.2016.11.053
|
[12]
|
Baker, R.S., Andersen, A.H., Morecraft, R.J. and Smith, C.D. (2003) A Functional Magnetic Resonance Imaging Study in Patients with Benign Essential Blepharospasm. Journal of Neu-ro-Ophthalmology, 23, 11-15.
https://doi.org/10.1097/00041327-200303000-00003
|
[13]
|
严志聪, 郭耀敏, 刘颖, 欧紫琳, 刘刚. 原发性眼睑痉挛患者脑网络中心度改变研究[J]. 中国神经精神疾病杂志, 2020, 46(9): 536-539.
|
[14]
|
王喜喜, 万新华. 眼睑痉挛的研究进展[J]. 中国神经免疫学和神经病学杂志, 2022, 29(5): 404-408+413.
|
[15]
|
蒋怡, 周华祥, 陈家利, 等. 特发性眼睑痉挛的中西医治疗进展[J]. 中国中医眼科杂志, 2019, 29(5): 424-427.
|
[16]
|
Conte, A., Berardelli, I., Ferrazzano, G., et al. (2016) Non-Motor Symptoms in Patients with Adult-Onset Focal Dystonia: Sensory and Psychiat-ric Disturbances. Parkinsonism & Related Disorders, 22, S111-S114.
https://doi.org/10.1016/j.parkreldis.2015.09.001
|
[17]
|
Duarte, G.S., Rodrigues, F.B., Marques, R.E., et al. (2020) Botulinum Toxin Type A Therapy for Blepharospasm. Cochrane Database of Systematic Reviews, 11, Article ID: CD004900. https://doi.org/10.1002/14651858.CD004900.pub3
|
[18]
|
Zanetti, G., Azarnia Tehran, D., Pirazzini, M., et al. (2015) Inhibition of Botulinum Neurotoxins Interchain Disulfide Bond Reduction Prevents the Peripheral Neuro-paralysis of Botulism. Biochemical Pharmacology, 98, 522-530.
https://doi.org/10.1016/j.bcp.2015.09.023
|
[19]
|
Durand, P.D., Couto, R.A., Isakov, R., et al. (2016) Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect. Aesthetic Surgery Journal, 36, 482-487. https://doi.org/10.1093/asj/sjv208
|
[20]
|
童庭辉, 黄文博, 侯海鑫, 黄丽容. 两种稀释度A型肉毒毒素治疗腋臭的疗效比较研究[J]. 中国全科医学, 2019, 22(2): 220-223.
|
[21]
|
Matak, I. and Lacković, Z. (2014) Botulinum Toxin A, Brain and Pain. Progress in Neurobiology, 119-120, 39-59.
https://doi.org/10.1016/j.pneurobio.2014.06.001
|
[22]
|
Rosales, R.L. and Dressler, D. (2010) On Muscle Spindles, Dystonia and Botulinum Toxin. European Journal of Neurology, 17, 71-80. https://doi.org/10.1111/j.1468-1331.2010.03056.x
|
[23]
|
Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O. and Caleo, M. (2008) Long-Distance Retrograde Effects of Botulinum Neurotoxin A. Journal of Neuroscience, 28, 3689-3696. https://doi.org/10.1523/JNEUROSCI.0375-08.2008
|
[24]
|
Tang, M., Li, W., Ji, F., et al. (2019) Impact of Botulinum Toxin Injections on Quality of Life and Self-Esteem in Patients with Blepharospasm. Psychology, Health & Medicine, 24, 513-518.
https://doi.org/10.1080/13548506.2018.1549740
|
[25]
|
Boyle, M.H., McGwin Jr., G., Flanagan, C.E., Vicinanzo, M.G. and Long, J.A. (2009) High versus Low Concentration Botulinum Toxin A for Benign Essential Blepharospasm: Does Dilution Make a Difference? Ophthalmic Plastic & Reconstructive Surgery, 25, 81-84. https://doi.org/10.1097/IOP.0b013e31819946c4
|
[26]
|
Hassell, T.J.W. and Charles, D. (2020) Treatment of Ble-pharospasm and Oromandibular Dystonia with Botulinum Toxins. Toxins, 12, Article No. 269. https://doi.org/10.3390/toxins12040269
|
[27]
|
Dabrowski, E., Bonikowski, M., Gormley, M., et al. (2018) AbobotulinumtoxinA Efficacy and Safety in Children with Equinus Foot Previously Treated with Botulinum Toxin. Pe-diatric Neurology, 82, 44-49.
https://doi.org/10.1016/j.pediatrneurol.2017.12.013
|